Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer

British Journal of Pharmacology(2023)10.1111/bph.16289Source: DataRank Database

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer is a research paper published in British Journal of Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen hpa refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.37)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Andrea Serratore ORCID,Jonathan R. Perri,Tista Roy Chaudhuri ORCID,Jun Qu ORCID,Wen Wee ORCID

Live enrichment

PubMed:37994108 PMC:PMC11909478 OpenAlex:https://openalex.org/W4388940025

National Cancer Institute

Grant: P30CA016056

National Cancer Institute

Grant: R01CA198096

National Cancer Institute

Grant: R21CA168454

National Cancer Institute

Grant: RO3CA205178

National Center for Advancing Translational Sciences

Grant: UL1TR001412

NCI NIH HHS

Grant: R03 CA205178

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16289

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16289

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bph.16289

journalhttps://doi.org/10.1111/bph.16289

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37994108

Fields of Study

Fibroblast Growth Factor ResearchPancreatic and Hepatic Oncology ResearchProteoglycans and glycosaminoglycans research

MeSH Terms

GemcitabineAdenocarcinomaHumansPancreatic NeoplasmsCell Line, TumorReceptor, Fibroblast Growth Factor, Type 1

Keywords

Fibroblast growth factor receptorFibroblast growth factor receptor 3Fibroblast growth factor receptor 4Fibroblast growth factor receptor 2Pancreatic cancerFibroblast growth factor receptor 1ReceptorCancer researchFibroblast growth factorGrowth factor receptorGrowth factor receptor inhibitorFGF1Growth factorBiologyInternal medicineEndocrinologyCancerMedicineFgfr InhibitorsInverse CorrelationFgfr1 PathwayFgfr1 Expression

Sustainable Development Goals

SDG 0: No poverty